EIKN
Eikon Therapeutics, Inc.
7.50$
+2.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 46.4% | 60.8% | 58.7% | 62.2% | 70.2% | |
| 26.3% | 16.3% | 17.6% | 19.0% | 18.3% | |
| – | 58.5% | 56.5% | 60.2% | 68.2% | |
| 216.4% | 225.2% | 247.8% | 35.3% | 40.2% | |
| 11.5% | 6.9% | 9.2% | 5.3% | 7.1% | |
| – | 1.5% | 1.7% | 1.1% | 1.2% | |
| 3.6% | 0.7% | 0.1% | 0.7% | 0.8% | |
| -116.4% | -125.2% | -147.8% | 64.7% | 59.8% | |
| -123.1% | -130.9% | -154.8% | -117.9% | -140.1% | |
| 11.0% | 8.4% | 9.1% | 6.4% | 6.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.